Grandway Advised Bide Pharmatech on Listing on the SSE STAR Market

On October 11, 2022, Bide Pharmatech Co., Ltd. (“Bide Pharmatech”) was listed on the SSE STAR Market. Bide Pharmatech issued 16.2291 million shares, with stock code 688073.

Bide Pharmatech is a high-tech enterprise focusing on the front-end of the new drug R&D industry chain, relying on the core business of R&D, design, production and sales of drug molecular blocks, and able to provide new drug R&D institutions with novel structure and various functions of drug molecular blocks and scientific reagents and other products. The company will continue to pay close attention to the development trend of global biopharmaceutical industry, take advantage of its existing technology and resources, continue to cultivate new drug R&D services and industrialization application market, and further increase its comprehensive ability to serve global pharmaceutical R&D institutions through continuous R&D innovation and joint development with clients and suppliers.